Login
Toggle navigation
Videos
Categories
Trending
Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Debt Management Tips for Dentists: How to Navigate Student Loans and Financial Planning
00:10:00
Northwest Fund: Stable Returns with 9% Note Rate and Predictable Performance
00:10:00
What to Look for in a Financial Advisor
00:10:00
Lepidico: Revolutionizing Lithium Production from Mine to Chemicals
00:10:00
Navigating Grief: Coping with the Loss of a Loved One | Ron Bernstein - Co-Founder and Managing Partner, Prism Planning Partners
00:10:00
Ousmane Diop: Leading Climate Innovation in Africa
00:10:00
Longview's Commitment to Client-Centered Financial Advisory | Jessica Smith, President, Longview Financial Advisors, Inc..
00:10:00
Strategic Planning for Optimal Financial Aid Awards | Ken Robinson, Owner, Practical Financial Planning.
00:10:00
"Exploring Eduardo Gallardo: An Insightful Profile" | Eduardo Gallardo - Partner, Corporate Department of Paul Hastings LLP
00:10:00
Biotech Company Sees Strong Growth Amid Focus on Sustainability and Circular Economy |Gabriella Colucci, CEO, Arterra Bioscience S P A.
00:10:00
Transforming Manufacturing and Industrial Businesses|David Shapiro,Managing Partner, KPS Capital Partners
00:10:00
How his company makes MicroStation easier|David Greenbaum,Founder and CEO,Axiom's